Biomarker Identification through Proteomics in Colorectal Cancer
International Journal of Molecular Sciences · 14.02.2024 · 25 (4) · 2283
DOI: 10.3390/ijms25042283 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.02.2024. Verfasst von Desirée Martín-García und 2 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Specialties, Biochemistry and Immunology Department, Faculty of Medicine, University of Málaga, 29010 Málaga, Spain. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Colorectal Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Social Fund-Operational Program of Andalusia 2014-2020, University of Malaga, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Colorectal cancer (CRC) is a devastating disease that ranks third in diagnosis and as the second leading cause of cancer-related deaths. The early detection of CRC has been shown to be the most effective strategy to improve treatment outcomes and patient survival. Therefore, current lines of research focus on the development of reliable diagnostic tools. Targeted therapies, in combination with standard chemotherapy and immune checkpoint inhibitors, have emerged as promising treatment protocols in CRC. However, their effectiveness is linked to the molecular characteristics of each patient. The importance of discovering biomarkers that help predict response to therapies and assess prognosis is evident as they allow for a fundamental step towards personalized care and successful treatments. Among the ongoing efforts to identify them, mass spectrometry-based translational proteomics presents itself as a unique opportunity as it enables the discovery and application of protein biomarkers that may revolutionize the early detection and treatment of CRC. Our objective is to show the most recent studies focused on the identification of CRC-related protein markers, as well as to provide an updated view of advances in the field of proteomics and cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Surgical Specialties, Biochemistry and Immunology Department, Faculty of Medicine, University of Málaga, 29010 Málaga, Spain.
- Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), 29590 Málaga, Spain.
- Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, 29590 Málaga, Spain.
- Research and Innovation Unit, Hospital Universitario Costa del Sol, 29602 Marbella, Spain.
ORCID-Profile: Marilina García-Aranda
Förderung
- European Social Fund-Operational Program of Andalusia 2014-2020
- University of Malaga
- Instituto de Salud Carlos III
- European Regional Development fund
- European Social Fund—Operational Program of Andalusia 2014–2020
- University of Malaga—Consejería de Transformación Económica, Industria, Conocimiento y Universidades—Junta de Andalucia
- European Regional Development
Zitieren
APA
Martín-García, D., García-Aranda, M., & Redondo, M. (2024). Biomarker Identification through Proteomics in Colorectal Cancer. International Journal of Molecular Sciences, 25(4), 2283. https://doi.org/10.3390/ijms25042283
Vancouver
Martín-García D, García-Aranda M, Redondo M. Biomarker Identification through Proteomics in Colorectal Cancer. International Journal of Molecular Sciences. 2024;25(4):2283. doi:10.3390/ijms25042283
BibTeX
@article{MartnGarca2024,
author = {Martín-García, Desirée and García-Aranda, Marilina and Redondo, Maximino},
title = {Biomarker Identification through Proteomics in Colorectal Cancer},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {4},
pages = {2283},
doi = {10.3390/ijms25042283}
}
EUVIMED